Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) Stock Short Interest Report for September

Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) was the target of a large increase in short interest during the month of September. As of September 30th, there was short interest totaling 65 shares, an increase of 170.8% from the September 15th total of 24 shares. Based on an average daily trading volume, of 1,647 shares, the short-interest ratio is currently 0.0 days. Currently, 0.0% of the shares of the company are sold short.

Innovator IBD Breakout Opportunities ETF Trading Down 0.3%

BOUT stock traded down $0.11 during mid-day trading on Monday, hitting $43.06. 366 shares of the company were exchanged, compared to its average volume of 3,523. The business has a 50 day simple moving average of $44.20 and a 200-day simple moving average of $44.94. The stock has a market capitalization of $15.07 million, a PE ratio of 28.69 and a beta of 1.04. Innovator IBD Breakout Opportunities ETF has a 1-year low of $35.05 and a 1-year high of $49.41.

Innovator IBD Breakout Opportunities ETF Company Profile

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.